Benjamin J. Eckhardt
Impact in
- Hepatology top 2%
- Hepatitis C virus research
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- HIV/AIDS Research and Interventions
Papers in
- Hepatology 19
- Hepatitis C virus research 19
-
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 and COVID-19 Research 4
- HIV/AIDS drug development and treatment 2
- HIV/AIDS Research and Interventions 1
- Co-authors
- Brian R. Edlin (4 shared papers)Marla A. Shu (2 shared papers)Tracy Swan (1 shared paper)Scott D. Holmberg (1 shared paper)Kristen Marks (11 shared papers)Pedro Mateu‐Gelabert (16 shared papers)Shashi N. Kapadia (15 shared papers)Chunki Fong (12 shared papers)
- Journals
- Open Forum Infectious Diseases (4 papers)Harm Reduction Journal (3 papers)PLoS ONE (3 papers)JAMA Network Open (3 papers)Clinical Infectious Diseases (1 paper)
- Partner nations
- United StatesKenyaCanada
In The Last Decade
Benjamin J. Eckhardt
37 papers receiving 979 citations
Benjamin J. Eckhardt's Hit Papers
Peers
Comparison fields: 5 of 69
- Hepatology 521
- Infectious Diseases 168
- Epidemiology 221
- Emergency Medicine 43
- Public Health, Environmental and Occupational Health 69
Countries citing papers authored by Benjamin J. Eckhardt
This map shows the geographic impact of Benjamin J. Eckhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin J. Eckhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin J. Eckhardt more than expected).
Fields of papers citing papers by Benjamin J. Eckhardt
This network shows the impact of papers produced by Benjamin J. Eckhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin J. Eckhardt. The network helps show where Benjamin J. Eckhardt may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin J. Eckhardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Toward a more accurate estimate of the prevalence of hepatitis C in the United States Hit paper breakdown → | 2015 | 352 |
| 2 | 2022 | 96 | |
| 3 | 2022 | 54 | |
| 4 | 2017 | 52 | |
| 5 | 2021 | 48 | |
| 6 | 2012 | 45 | |
| 7 | 2018 | 45 | |
| 8 | 2019 | 44 | |
| 9 | 2020 | 33 | |
| 10 | 2021 | 30 | |
| 11 | 2022 | 21 | |
| 12 | 2022 | 19 | |
| 13 | 2022 | 18 | |
| 14 | 2012 | 17 | |
| 15 | 2019 | 17 | |
| 16 | 2016 | 16 | |
| 17 | 2023 | 14 | |
| 18 | 2023 | 14 | |
| 19 | 2020 | 12 | |
| 20 | Rapid Treatment Initiation for Hepatitis C Virus Infection: Potential Benefits, Current Limitations, and Real-World Examples. | 2022 | 11 |
About Benjamin J. Eckhardt
Benjamin J. Eckhardt is a scholar working on Hepatology, Infectious Diseases, Epidemiology, Emergency Medicine and Parasitology, having authored 38 papers that have together received 1k indexed citations. Recurring topics across this work include Hepatitis C virus research (19 papers), HIV, Drug Use, Sexual Risk (10 papers), COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), HIV-related health complications and treatments (2 papers), HIV/AIDS drug development and treatment (2 papers), Vitamin D Research Studies (1 paper) and HIV/AIDS Research and Interventions (1 paper). The work is most often cited by research in Hepatology (521 citations), Infectious Diseases (168 citations), Epidemiology (221 citations), Emergency Medicine (43 citations) and Public Health, Environmental and Occupational Health (69 citations). Benjamin J. Eckhardt has collaborated with scholars based in United States, Kenya and Canada. Frequent co-authors include Brian R. Edlin, Marla A. Shu, Tracy Swan, Scott D. Holmberg, Kristen Marks, Pedro Mateu‐Gelabert, Shashi N. Kapadia, Chunki Fong, Yesenia Aponte-Meléndez and Emily R. Winkelstein. Their work appears in journals such as Open Forum Infectious Diseases, Harm Reduction Journal, PLoS ONE, JAMA Network Open and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.